Please login to the form below

Not currently logged in
Email:
Password:

Janssen-Cilag

This page shows the latest Janssen-Cilag news and features for those working in and with pharma, biotech and healthcare.

CHMP backs maintenance therapy for Tesaro's Zejula

CHMP backs maintenance therapy for Tesaro's Zejula

CHMP meeting round-up. Aside from Zejula, at its last meeting the CHMP backed GlaxoSmithKline's triple chronic obstructive pulmonary disease (COPD) therapy Trelegy/Elebrato, Janssen-Cilag's Tremfya (guselkumab) for

Latest news

  • J&J gets CHMP backing for broader Darzalex use J&J gets CHMP backing for broader Darzalex use

    Janssen-Cilag has moved closer to an expanded label in the EU for its multiple myeloma drug Darzalex, allowing patients with earlier-stage disease to receive the drug.

  • GSK gene therapy tops CHMP recommendations GSK gene therapy tops CHMP recommendations

    Other decisions. Other positive opinions adopted by the CHMP included a conditional marketing authorisation for Darzalex (daratumumab), Janssen-Cilag's new candidate for relapsed and refractory multiple myeloma, which was approved ... Among other

  • J&J files three-monthly schizophrenia drug in Europe J&J files three-monthly schizophrenia drug in Europe

    s Janssen-Cilag unit. ... pain unit for Janssen in Europe.

  • EU approval for J&J’s hepatitis C drug EU approval for J&J’s hepatitis C drug

    The drug is to be marketed by J&J's subsidiary Janssen-Cilag and is approved for use alongside Gilead Sciences' Sovaldi (sofosbuvir), which was authorised in the region in January ... Janssen said that it now expects the drug to be available across a

  • EMA backs Janssen rare disease drug for approval EMA backs Janssen rare disease drug for approval

    EMA backs Janssen rare disease drug for approval. Castleman's disease treatment Sylvant wins CHMP recommendation. ... J&J subsidiary Janssen-Cilag's Castleman's disease treatment Sylvant (situximab) has been recommended for approval in Europe.

More from news
Approximately 2 fully matching, plus 67 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • J&J's Jane Griffiths named global head of Actelion J&J's Jane Griffiths named global head of Actelion

    Griffiths is currently company group chairman at J&J’s Janssen EMEA company and will step into her new role once its purchase of Actelion is completed. ... Prior to leading Janssen EMEA, Griffith was responsible for the EMEA market access unit, and her

  • Dr Brendan Murphy joins Portland Health Dr Brendan Murphy joins Portland Health

    He also brings experience from a number of agencies including Inspired Science, Ketchum, MediTech Media and pharmaceutical firm Janssen Cilag, where he served as its medical education manager.

  • Phil Tomlinson joins Star Outsourcing Phil Tomlinson joins Star Outsourcing

    Prior to that he served at Ashfield Commercial and Medical Services for eight years and worked industry-side at Janssen-Cilag as a senior regional business manager.

  • Havas Lynx announces changes to management team Havas Lynx announces changes to management team

    Before becoming the UK managing director of Across Health, Monk was product manager at Janssen Cilag, during which time he won a stream of industry awards (primarily with digital focus) including

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • No Voice, No Choice

    The research was commissioned by Rethink Mental Illness and undertaken by Adelphi Research UK, with support from Janssen Cilag Ltd. ... Rachel Medcalf, Managing Director, Adelphi Research UK commented:. “ It’ s great to be involved in this crucial

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GEM Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics